Transplantation and Cellular Therapy

Transplantation and Cellular Therapy is a subscription (hybrid open access) journal published by Elsevier BV in the Netherlands. OpenAlex counts 22,412 works from it, cited 291,889 times; its h-index is 177. Its two-year mean citedness, which is computed the way the impact factor is, is 1.58: a paper it published in the two years before was cited about 1.58 times last year. It published 1,230 papers in 2025, up 24% from 991 in 2024. Publishing a paper open access in it costs about US$3,650.

Publisher
Elsevier BV
Citations per paper
1.58 two-year mean, OpenAlex
h-index
177 i10-index 4,972
Access
Subscription · hybrid open access
APC
US$3,650 to publish open access
ISSN
1083-8791, 1523-6536, 2666-6367
Country
Netherlands
Works published
22,412 cited 291,889 times
Papers in 2025
1,230
Field
Medicine
Website
Journal home ↗

Transplantation and Cellular Therapy year by year

Papers it published each year, and the citations all its papers received that year.

YearPapers publishedCitations received
2026 so far1,47520,094
20251,23021,686
202499122,239
202396520,900
20221,03719,906
202197422,681
20201,03520,633
20191,13017,309

What Transplantation and Cellular Therapy publishes

Its most frequent research topics, by OpenAlex's topic classification.

Questions about Transplantation and Cellular Therapy

What is the impact factor of Transplantation and Cellular Therapy?

Clarivate's Journal Impact Factor is licensed and not shown here. OpenAlex's two-year mean citedness, computed the same way from open data, is 1.58 for Transplantation and Cellular Therapy: on average, each paper it published in the two years before was cited about 1.58 times in a year.

What is the h-index of Transplantation and Cellular Therapy?

177, by OpenAlex's count: 177 of its papers have each been cited at least 177 times. Its i10-index is 4,972.

Is Transplantation and Cellular Therapy open access?

Not fully. Transplantation and Cellular Therapy is a subscription journal; a paper is free to read when its authors paid for open access or posted a copy in a repository.

What is the publication fee (APC) of Transplantation and Cellular Therapy?

About US$3,650, which is the fee to publish a paper open access as listed by OpenAlex. Fees change and waivers exist, so check the journal's own page before you submit.

What is the ISSN of Transplantation and Cellular Therapy?

Its linking ISSN is 1083-8791; all its ISSNs: 1083-8791, 1523-6536, 2666-6367.

Who publishes Transplantation and Cellular Therapy?

Elsevier BV, based in the Netherlands.

How many papers does Transplantation and Cellular Therapy publish a year?

1,230 in 2025, by OpenAlex's count of what it published that year.

What does Transplantation and Cellular Therapy publish?

Its most frequent research topics are Hematopoietic Stem Cell Transplantation, Transplantation: Methods and Outcomes, Renal Transplantation Outcomes and Treatments, in the field of Medicine.

Is Transplantation and Cellular Therapy a predatory journal?

Nothing in the scholarly indexes suggests so. Transplantation and Cellular Therapy is on OpenAlex's list of core sources, journals with peer review and an editorial board, it has published 22,412 works cited 291,889 times. For a journal you do not know, check the red flags with our predatory journal checker.

Is Transplantation and Cellular Therapy indexed in Scopus or Web of Science?

Check the Scopus Sources list and Clarivate's Master Journal List by its ISSN (1083-8791): both are free to search. Our guide on checking journal indexing shows each step.

Journals like Transplantation and Cellular Therapy

Other Medicine journals with a similar impact.

Every Medicine journal, ranked · The journal directory

Journal data from OpenAlex (CC0), compiled 21 November 2026. Download the whole directory as a CSV file (CC BY 4.0).